Stampanoni Bassi, M.; Buttari, F.; Simonelli, I.; Gilio, L.; Furlan, R.; Finardi, A.; Marfia, G.A.; Visconti, A.; Paolillo, A.; Storto, M.;
et al. A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes 2020, 11, 1152.
https://doi.org/10.3390/genes11101152
AMA Style
Stampanoni Bassi M, Buttari F, Simonelli I, Gilio L, Furlan R, Finardi A, Marfia GA, Visconti A, Paolillo A, Storto M,
et al. A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes. 2020; 11(10):1152.
https://doi.org/10.3390/genes11101152
Chicago/Turabian Style
Stampanoni Bassi, Mario, Fabio Buttari, Ilaria Simonelli, Luana Gilio, Roberto Furlan, Annamaria Finardi, Girolama Alessandra Marfia, Andrea Visconti, Andrea Paolillo, Marianna Storto,
and et al. 2020. "A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment" Genes 11, no. 10: 1152.
https://doi.org/10.3390/genes11101152
APA Style
Stampanoni Bassi, M., Buttari, F., Simonelli, I., Gilio, L., Furlan, R., Finardi, A., Marfia, G. A., Visconti, A., Paolillo, A., Storto, M., Gambardella, S., Ferese, R., Salvetti, M., Uccelli, A., Matarese, G., Centonze, D., & De Vito, F.
(2020). A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes, 11(10), 1152.
https://doi.org/10.3390/genes11101152
